Counterpoint:

This was one of my favourite interviews so far. Thanks, MedicalGold.ca!

Our CEO, Nick Kadysh, sat down with MedicalGold to discuss our unique approach to getting a jump start on manufacturing a drug that has not achieved regulatory approval. (MDMA)

Read it here: medicalgold.ca/featured/exclu…

#psychedelics $MDMA #laneo

My two favourite fraud lab stories this week:

1) I saw a COA for 48.7% flower

2) An LP got over 40% THC and a clean COA only to realize that they never sent in the sample to the lab.

How has Health Canada and PHAC not started a recall program?

PharmAla Files Patent for Novel MDXX Molecule PharmAla-1:

psychedelicinvest.com/pharmala-files…

Q: Why will a good product with great distribution always beat a great product with bad distribution?

LinkedIn founder Reid Hoffman wrote in his book Blitzscaling:

'Many people in Silicon Valley like to focus on building products that are, in the famous words of the late Steve…

PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney:

psychedelicinvest.com/pharmala-recei…

Many thanks to Leah Mayo & Gillinder Bedi for raising some great points during our discussion this morning. We have a lot of work to do in the field of psychedelics. Here’s to more research & evidence based guidances & programs.

Join me via webinar on Wednesday, July 26th at 10 pm AEST/8 am EST as speakers from Canada’s PharmAla Biotech, and Leah Mayo from UCalgary, discuss the current FDA landscape and what the road to FDA/TGA approval looks like.

Register here: bit.ly/3rEEGqc

OH GOD YES THANK YOU

Nice to be recognized for the PharmAla team’s hard work.

Me, toiling in the MDMA(salts) mines.

As Australia legalizes prescription use of #psilocybin & MDMA, unlocking therapeutic potential and research opportunities, $MSET is collaborating with PharmAla Biotech to supply pharmaceutical-grade psilocybin for clinicians and researchers there.

bbc.com/news/world-aus…

PharmAla is pleased to announce that Cortexa, our Joint Venture with Australian company Vitura Health has executed its first purchase order for PharmAla’s GMP LaNeo MDMA, in both finished capsule and raw API forms. Cortexa will also be ordering an amount of GMP Psilocybin API.…

#MDMA now legal for medical use in Australia theguardian.com/australia-news…

This Kind Of Smart, Walkable, Mixed-use Urbanism Is Illegal To Build In Most American Cities

Psychedelics industry friends in the UK, join us!

listen. not to go full disco elysium on main again but like. this game.

We knew the world would not be the same. A few people laughed, a few people cried. Most were silent.

Our own Harpreet Kaur, leading a team of multidisciplinary specialists in computational modeling, drug discovery and preclinical research, has been published in the journal Psychedelic Medicine!

This publication represents our foundational scientific work. liebertpub.com/doi/10.1089/ps…